Apellis Pharmaceuticals to Present at the BofA Securities 2020 Health Care Conference
WALTHAM, Mass., May 08, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) a global biopharmaceutical company pioneering targeted C3 therapies, […]